| II-23 Francois Gaudreault Model based Phase 2 Dose Selection of BIIB059 in Subjects with Systemic and Cutaneous Lupus Erythematosus (SLE and CLE) Wednesday 15:50-17:20 |
| II-23 Francois Gaudreault Model based Phase 2 Dose Selection of BIIB059 in Subjects with Systemic and Cutaneous Lupus Erythematosus (SLE and CLE) Wednesday 15:50-17:20 |